Alerts will be sent to your verified email
Verify Email
LINCOLN
|
Lincoln Pharma
|
Kwality Pharma
|
Bharat Parenterals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.94 % | 25.27 % | 12.73 % |
|
5yr Avg Net Profit Margin
|
14.61 % | 11.66 % | 8.73 % |
|
Price to Book
|
1.62 | 3.89 | 2.88 |
|
P/E
|
12.58 | 23.69 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
24.49 Days | 55.02 Days | 122.06 Days |
|
5yr Average Interest Coverage Ratio
|
58.2 | 16.13 | 22.68 |
|
5yr Avg ROCE
|
20.48 % | 34.73 % | 16.02 % |
|
5yr Avg Operating Profit Margin
|
18.48 % | 23.23 % | 11.16 % |
|
5 yr average Debt to Equity
|
0.0 | 0.46 | 0.26 |
|
5yr CAGR Net Profit
|
12.65 % | 21.34 % | -9.67 % |
|
5yr Average Return on Assets
|
12.28 % | 12.96 % | 8.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.78 % | 54.83 % | 67.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.7 % | 0.38 % | -6.65 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Lincoln Pharma
|
Kwality Pharma
|
Bharat Parenterals
|
|---|